If you enjoy this content, please share it with a colleague
Volpara Solutions Limited
RELATED CONTENT
With the increased availability of and reliance on high-dose imaging modalities for rapid and comprehensive diagnosis ...
Researchers at the University of Virginia (UVA) Health System have demonstrated that automated volumetric fibroglandular breast density measurement tools are more precise than area-based methods. Results of the study, "Reliability of Automated Breast Density Measurements," recently featured in Radiology, suggest that with lower variability, volumetric breast density is well suited for inclusion in breast cancer risk models. The announcement was made at the Association for Medical Imaging Management (AHRA)'s 43rd annual meeting and exposition, July 19-22 in Las Vegas.
The first randomized trial investigating the additional value of magnetic resonance imaging (MRI) for screening women with dense breasts, is featured in the current issue of Radiology. The article, “MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50–75 Years with Extremely Dense Breasts: The DENSE Trial Study Design,†presents the rationale and design of the DENSE Trial. Run by Carla van Gils, M.D., and Wouter Veldhuis, M.D., from University Medical Center Utrecht (UMCU) in the Netherlands, the trial seeks to determine the effectiveness of screening with mammography and MRI compared to mammography alone in women who have extremely dense breasts.
Volpara Solutions announced the release of VolparaDensity version 3.1 at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Florida, April 25-28.
Volpara Solutions announced the installation of VolparaDensity in Belgium, marking the 31st country where the system has been implemented. New installations were also recently completed in Canada, Turkey, Korea, Japan and the United Kingdom.
Ten abstracts on the uses of volumetric breast imaging data were presented at the 2015 European Congress of Radiology (ECR) meeting, focusing on reducing subjectivity in density and assessment and improving breast cancer risk prediction models.
Of all the departments in a hospital, radiology arguably holds the most and richest variety of data. There’s so much data, in fact, that it can be difficult to know what to do with it all and how to handle it. As the healthcare industry continues to shift toward a value-based payment model, utilizing that data becomes even more important as hospitals take a look at their operations and try to improve their performance. For radiology departments struggling with information overload, business analytics can provide a solution.
Calculating and tracking mammographic compression pressure could help standardize mammography quality and patient experience, according to a study published in the European Jorunal of Radiology (EJR).
Multiple studies and products were presented at the 2014 Radiological Society of North America (RSNA) conference in December about emerging technologies in breast imaging, with a focus on how they will affect women who have dense breasts. Most researchers have been comparing the utility of mammography screening versus tomosynthesis.
To help improve breast cancer screening for the 40 percent of American women with dense breasts, Volpara Solutions announced it has signed an agreement enabling GE Healthcare to distribute VolparaDensity, VolparaAnalytics and VolparaDoseRT.